- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hematologic Malignancies in United Kingdom
Total 8398 results
-
University of PittsburghAmerican College of Radiation OncologyNot yet recruitingUpper Abdominal MalignanciesUnited States
-
Summa Health SystemTerminatedAdvanced Bulky MalignanciesUnited States
-
Synta Pharmaceuticals Corp.CompletedSolid Tumor MalignanciesUnited States
-
Weill Medical College of Cornell UniversityTerminatedSolid Tumor MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced MalignanciesUnited States
-
University of KentuckyArno TherapeuticsCompleted
-
Heidelberg Pharma AGUnited States Department of DefenseCompletedAdvanced MalignanciesUnited States
-
Sally AraiCompletedLeukemia | Multiple MyelomaUnited States
-
Humanigen, Inc.SuspendedMyelodysplastic Syndrome (MDS) | Myelofibrosis (MF)United States, Australia
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLCRecruitingPneumonia | Hematologic Malignancy | Pseudomonas AeruginosaUnited States
-
Curis, Inc.RecruitingRelapsed Primary Central Nervous System Lymphoma | Refractory Hematologic Malignancy | Relapsed Hematologic Malignancy | Refractory Primary Central Nervous System LymphomaUnited States, Spain, France, Czechia, Israel, Italy, Poland
-
University of Alabama at BirminghamNot yet recruitingMyelodysplastic Syndromes | Primary Myelofibrosis | AML | Lymphoid Malignancies | CML | ALLUnited States
-
Washington University School of MedicineCompletedResistant Solid MalignanciesUnited States
-
Mirati Therapeutics Inc.CompletedAdvanced MalignanciesUnited States
-
Novartis PharmaceuticalsTerminatedAdvanced MalignanciesUnited States
-
CCTU- Cancer ThemeRecruitingCancer | Non-Hematologic MalignancyUnited Kingdom
-
Incyte CorporationWithdrawnSolid Tumors and Hematologic Malignancy | NSCLC (Non-small Cell Lung Carcinoma)United States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedMultiple Myeloma | Hodgkin's Lymphoma | AML | Hematologic Malignancy | NHL | CML | ALLUnited States
-
Incyte CorporationTerminatedSolid Tumors and Hematologic MalignancyUnited States
-
MedImmune LLCCompletedAdvanced MalignanciesUnited States
-
Sigma-Tau Research, Inc.Dana-Farber Cancer Institute; Rhode Island HospitalCompletedSolid MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States
-
University of Illinois at ChicagoCompletedIntensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies (IM-TMI)Acute Myeloid Leukemia | Chronic Myeloid Leukemia | Acute Leukemia | Lymphoblastic Leukemia | Non Hodgkins LymphomaUnited States
-
St. Jude Children's Research HospitalCompletedAcute Lymphoblastic Leukemia | Non-Hodgkins Lymphoma | Hodgkin's DiseaseUnited States
-
Sumitomo Pharma America, Inc.CompletedCancer, Advanced MalignanciesCanada, United States
-
Athenex, Inc.RecruitingAdvanced Solid MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedA Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionAdvanced Malignancies | TumorsUnited States
-
Imperial College Healthcare NHS TrustCompleted
-
Georgetown UniversityPfizerUnknownAdvanced Solid Tumor MalignanciesUnited States
-
M.D. Anderson Cancer CenterNot yet recruitingMyeloid Malignancies | Lymphodepleting ChemotherapyUnited States
-
M.D. Anderson Cancer CenterReata Pharmaceuticals, Inc.CompletedSolid Tumors | Lymphoid MalignanciesUnited States
-
St. Jude Children's Research HospitalTerminatedAcute Myeloid Leukemia | Acute Lymphoid Leukemia | Mixed Lineage Acute LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawnHistologically-confirmed MalignanciesUnited States
-
R-PharmCompletedSolid MalignanciesUnited States
-
UNC Lineberger Comprehensive Cancer CenterNot yet recruitingLymphoma | Leukemia | Multiple Myeloma | Hematologic Malignancies | Blood CancersUnited States
-
New Mexico Cancer Care AllianceCompletedAdvanced Solid Tumor MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedLymphoma | Multiple Myeloma | Hodgkin Lymphoma | Hematologic MalignanciesUnited States
-
Infinity Pharmaceuticals, Inc.Terminated
-
Novartis PharmaceuticalsTerminated
-
Bristol-Myers SquibbTerminatedAdvanced Solid MalignanciesUnited States, Canada
-
National Cancer Institute (NCI)CompletedLymphoma | Leukemia | Multiple Myeloma | Hematologic Malignancy | Solid Tumor MalignancyUnited States
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruitingPart 1:r/r B-cell Malignancies | Part 2:B-cell MalignanciesUnited States, Poland, Israel, Ukraine
-
Regeneron PharmaceuticalsWithdrawnAdvanced MalignanciesUnited States
-
Incyte CorporationActive, not recruitingB-cell MalignanciesUnited States
-
Eisai Inc.CompletedSolid Tumor Malignancies, CancerUnited States
-
Incyte CorporationCompleted
-
Mesoblast International SàrlNational Cancer Institute (NCI)WithdrawnMyelodysplastic Syndromes | Leukemia | Graft Versus Host DiseaseUnited States
-
Agios Pharmaceuticals, Inc.CompletedMyelodysplastic Syndrome | Hematologic Malignancies | Acute Myeloid Leukemia (AML)United States, France
-
Cerus CorporationCompletedThrombocytopeniaUnited Kingdom
-
Regeneron PharmaceuticalsTerminatedAdvanced PD-L1 Positive MalignanciesUnited States